Nectar Lifescience Ltd.
| BSE: 532649 | Sector: Health care |
| NSE: NECLIFE | ISIN Code: INE023H01027 |
| BSE 00:00 | 26 Feb | 19.95 |
-0.30 (-1.48%) |
OPEN
20.60 |
HIGH
20.75 |
LOW
19.80 |
| NSE 00:00 | 26 Feb | 20.10 |
0 (0.00%) |
OPEN
20.25 |
HIGH
20.75 |
LOW
19.80 |
| OPEN | 20.60 |
| PREVIOUS CLOSE | 20.25 |
| VOLUME | 100334 |
| 52-Week high | 30.05 |
| 52-Week low | 7.20 |
| P/E | |
| Mkt Cap.(Rs cr) | 447 |
| Buy Price | 20.00 |
| Buy Qty | 300.00 |
| Sell Price | 20.40 |
| Sell Qty | 2384.00 |
Nectar Lifescience Ltd. (NECLIFE) - Competition
| COMPANY | Last Price | Market Cap. (Rs. cr.) |
Sales Turnover | Net Profit | Total Assets |
| Sun Pharma.Inds. | 595.30 | 142,830.32 | 12,531.93 | 3,211.14 | 32,355.78 |
| Divi's Lab. | 3,368.25 | 89,410.20 | 5,310.57 | 1,372.71 | 7,370.84 |
| Dr Reddy's Labs | 4,424.60 | 73,581.10 | 11,850.40 | 2,937.70 | 16,732.90 |
| Cipla | 786.55 | 63,431.32 | 12,659.15 | 2,318.17 | 17,704.77 |
| Aurobindo Pharma | 854.90 | 50,088.59 | 13,266.48 | 1,872.74 | 16,809.46 |
| Biocon | 390.00 | 46,800.00 | 1,988.40 | 440.90 | 7,583.50 |
| Lupin | 1,018.50 | 46,204.25 | 11,025.66 | 727.55 | 17,937.29 |
| Cadila Health. | 434.75 | 44,505.36 | 6,347.40 | 1,412.90 | 15,089.80 |
| Apollo Hospitals | 3,060.50 | 44,003.87 | 9,794.50 | 470.30 | 8,570.00 |
| Piramal Enterp. | 1,828.50 | 41,241.82 | 4,219.19 | 144.85 | 33,415.39 |
| Torrent Pharma. | 2,429.55 | 41,112.85 | 6,168.44 | 938.51 | 10,683.66 |
| Gland Pharma | 2,401.50 | 39,264.53 | 2,633.24 | 772.86 | 3,653.86 |
| Alkem Lab | 2,718.60 | 32,500.86 | 6,677.08 | 1,264.42 | 7,728.19 |
| Abbott India | 14,396.65 | 30,592.88 | 4,093.14 | 592.93 | 2,691.43 |
| Glaxosmi. Pharma | 1,460.70 | 24,745.72 | 3,224.68 | 110.05 | 2,129.60 |
| Ipca Labs. | 1,849.30 | 23,458.37 | 4,367.43 | 652.46 | 4,185.23 |
| Syngene Intl. | 558.85 | 22,354.00 | 2,011.90 | 411.50 | 3,313.70 |
| Pfizer | 4,550.70 | 20,819.45 | 2,151.65 | 509.13 | 3,534.54 |
| Dr Lal Pathlabs | 2,301.75 | 19,182.78 | 1,273.60 | 223.18 | 1,106.64 |
| Sanofi India | 8,268.85 | 19,043.16 | 3,070.60 | 414.20 | 2,496.40 |
Quick Links for Nectar Lifescience:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
